JPWO2019215316A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019215316A5 JPWO2019215316A5 JP2020563691A JP2020563691A JPWO2019215316A5 JP WO2019215316 A5 JPWO2019215316 A5 JP WO2019215316A5 JP 2020563691 A JP2020563691 A JP 2020563691A JP 2020563691 A JP2020563691 A JP 2020563691A JP WO2019215316 A5 JPWO2019215316 A5 JP WO2019215316A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- triazolo
- pyrrolidine
- trimethyl
- pyrimidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862670075P | 2018-05-11 | 2018-05-11 | |
| US62/670,075 | 2018-05-11 | ||
| PCT/EP2019/062020 WO2019215316A1 (en) | 2018-05-11 | 2019-05-10 | Triazolopyrimidine compounds and their use in treating cancer |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021523177A JP2021523177A (ja) | 2021-09-02 |
| JPWO2019215316A5 true JPWO2019215316A5 (https=) | 2022-05-16 |
| JP2021523177A5 JP2021523177A5 (https=) | 2022-05-16 |
| JP7418353B2 JP7418353B2 (ja) | 2024-01-19 |
Family
ID=66484070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020563691A Active JP7418353B2 (ja) | 2018-05-11 | 2019-05-10 | トリアゾロピリミジン化合物およびがんの処置におけるそれらの使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11084827B2 (https=) |
| EP (2) | EP4134368A1 (https=) |
| JP (1) | JP7418353B2 (https=) |
| KR (1) | KR102863374B1 (https=) |
| CN (3) | CN112469721B (https=) |
| AR (1) | AR115384A1 (https=) |
| AU (1) | AU2019264826B2 (https=) |
| BR (1) | BR112020023068A2 (https=) |
| CA (1) | CA3099579A1 (https=) |
| DK (1) | DK3790879T3 (https=) |
| ES (1) | ES2927244T3 (https=) |
| MX (1) | MX2020012058A (https=) |
| PT (1) | PT3790879T (https=) |
| TW (1) | TWI823932B (https=) |
| UY (1) | UY38228A (https=) |
| WO (1) | WO2019215316A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI823932B (zh) * | 2018-05-11 | 2023-12-01 | 中國大陸商迪哲（江蘇）醫藥有限公司 | 三唑并嘧啶化合物及其在治療癌症中之用途 |
| WO2021174176A1 (en) * | 2020-02-28 | 2021-09-02 | Remix Therapeutics Inc. | Pyridazine dervatives for modulating nucleic acid splicing |
| US20230192704A1 (en) * | 2020-05-21 | 2023-06-22 | Teon Therapeutics, Inc. | Monocarboxylic acid transporter 4 (mct4) modulators and uses thereof |
| WO2021249969A1 (en) * | 2020-06-10 | 2021-12-16 | Merck Patent Gmbh | Combination product for the treatment of cancer diseases |
| WO2022090527A1 (en) | 2020-11-02 | 2022-05-05 | Ares Trading S.A. | Combination treatment of cancer |
| WO2022243573A1 (en) | 2021-05-21 | 2022-11-24 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | 1,2,4-triazolo[1,5-a]pyrimidine-based slc16a3 inhibitors and their therapeutic use |
| WO2022243574A1 (en) | 2021-05-21 | 2022-11-24 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | 3-(phthalazin-1-yl)benzenesulfonamide-based slc16a3 inhibitors and their therapeutic use |
| CN120699024A (zh) * | 2024-03-25 | 2025-09-26 | 北京福元医药股份有限公司 | Mct4抑制剂及其药物组合物和用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040072746A1 (en) * | 2001-10-16 | 2004-04-15 | Michael Sullivan | Inhibitors of monocarboxylate transport |
| SE0300119D0 (sv) | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| DE102005034905A1 (de) | 2005-07-26 | 2007-02-01 | Federal-Mogul Nürnberg GmbH | Verfahren zur Herstellung eines Kolbens für einen Verbrennungsmotor sowie Kolben für einen Verbrennungsmotor |
| WO2010089580A1 (en) | 2009-02-06 | 2010-08-12 | Astrazeneca Ab | Use of a mct1 inhibitor in the treatment of cancers expressing mct1 over mct4 |
| WO2011114148A1 (en) | 2010-03-17 | 2011-09-22 | Astrazeneca Ab | 4h- [1, 2, 4] triazolo [5, 1 -b] pyrimidin-7 -one derivatives as ccr2b receptor antagonists |
| US10328078B2 (en) * | 2015-01-22 | 2019-06-25 | The Scripps Research Institute | Pteridine dione monocarboxylate transporter inhibitors |
| CA2974697A1 (en) * | 2015-01-22 | 2016-07-28 | The Scripps Research Institute | Pyrimidine-2,4-(1h,3h)-dione derivatives and pharmaceutical compositions thereof and their use as inhibitors of monocarboxylate transporters |
| BR112017026535B1 (pt) * | 2015-06-12 | 2023-12-19 | Vettore, LLC | Composto e composição farmacêutica |
| EP3455207A4 (en) * | 2016-05-12 | 2019-10-09 | Regents of the University of Minnesota | INDOL AND INDAZOCYANOCINNAMATE COMPOUNDS AND THERAPEUTIC USES THEREOF |
| TWI823932B (zh) * | 2018-05-11 | 2023-12-01 | 中國大陸商迪哲（江蘇）醫藥有限公司 | 三唑并嘧啶化合物及其在治療癌症中之用途 |
-
2019
- 2019-05-07 TW TW108115719A patent/TWI823932B/zh active
- 2019-05-10 CN CN201980046079.2A patent/CN112469721B/zh active Active
- 2019-05-10 DK DK19723404.0T patent/DK3790879T3/da active
- 2019-05-10 AR ARP190101254A patent/AR115384A1/es unknown
- 2019-05-10 EP EP22181542.6A patent/EP4134368A1/en active Pending
- 2019-05-10 MX MX2020012058A patent/MX2020012058A/es unknown
- 2019-05-10 EP EP19723404.0A patent/EP3790879B1/en active Active
- 2019-05-10 JP JP2020563691A patent/JP7418353B2/ja active Active
- 2019-05-10 CN CN202210528893.1A patent/CN115028637B/zh active Active
- 2019-05-10 BR BR112020023068-5A patent/BR112020023068A2/pt active Search and Examination
- 2019-05-10 WO PCT/EP2019/062020 patent/WO2019215316A1/en not_active Ceased
- 2019-05-10 UY UY38228A patent/UY38228A/es not_active Application Discontinuation
- 2019-05-10 CA CA3099579A patent/CA3099579A1/en active Pending
- 2019-05-10 ES ES19723404T patent/ES2927244T3/es active Active
- 2019-05-10 PT PT197234040T patent/PT3790879T/pt unknown
- 2019-05-10 CN CN202210528891.2A patent/CN115028636A/zh active Pending
- 2019-05-10 AU AU2019264826A patent/AU2019264826B2/en active Active
- 2019-05-10 KR KR1020207035470A patent/KR102863374B1/ko active Active
-
2020
- 2020-11-11 US US17/095,729 patent/US11084827B2/en active Active
-
2021
- 2021-07-05 US US17/367,450 patent/US11851432B2/en active Active
-
2023
- 2023-11-14 US US18/508,257 patent/US12503473B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523177A5 (https=) | ||
| US20230146795A1 (en) | Enhancement of anti-tumor activity of shp2 inhibitor pyrimidinone in combination with novel cancer medicines in cancers | |
| JP2025535046A (ja) | Ｋｒａｓ ｇ１２ｃ変異タンパク質の複素環阻害剤及びその使用 | |
| US10766902B2 (en) | Wee-1 inhibiting pyrazolopyrimidinone compounds | |
| US20220363696A1 (en) | Amino-substituted heterocycles for treating cancers with egfr mutations | |
| US20250122222A1 (en) | Heterocyclic compounds and methods of use | |
| US20230406860A1 (en) | Heterocyclic spiro compounds and methods of use | |
| EP4705293A1 (en) | Spiro-heterocyclic inhibitors of kras g12c mutant proteins and uses thereof | |
| US9708295B2 (en) | Substituted 2-aminopyridine protein kinase inhibitor | |
| JP2011511034A5 (https=) | ||
| JP2013523884A5 (https=) | ||
| JP2012525395A5 (https=) | ||
| JP2012501312A5 (https=) | ||
| IL297481A (en) | Halogenated heteroaryls and other heterocyclic kinase inhibitors, and uses thereof | |
| CN105732637B (zh) | 杂芳化合物及其在药物中的应用 | |
| US11529350B2 (en) | Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof | |
| JPWO2019215316A5 (https=) | ||
| KR102912146B1 (ko) | 시클로알칸-1,3-디아민 유도체 | |
| RU2020138615A (ru) | Триазолпиримидиновые соединения и их применение в лечении рака | |
| US20240217968A1 (en) | Pharmaceutical compound | |
| RU2022129897A (ru) | Галогенированные гетероарильные и другие гетероциклические ингибиторы киназы и их применение | |
| WO2025217247A1 (en) | Tethered spiro-heterocyclic inhibitors of kras g12c mutant proteins and uses thereof | |
| WO2025230878A1 (en) | Macrocyclic compounds as modulators of kras and uses thereof | |
| HK40107335A (en) | Fgfr inhibitors and methods of use thereof | |
| HK40070481A (en) | Fgfr inhibitors and methods of use thereof |